AIDS Seminar
Large Community Outbreak of HIV-1 Infection Linked to Injection Drug Use of Oxymorphone - Indiana, 2015
Tuesday, January 9, 2018, 10:30-11:30am
Dita Broz, PhD - CDC
NYU Meyers, 433 First Ave, Conference Room 760
Find more information HERE.

AIDS Seminar
Qualitative and Mixed Methods in Implementation Science: Finding the Right Balance
Tuesday, February 13, 10:30-11:30am
Deborah Padgett, PhD, MPH - NYU Silver
NYU Meyers, 433 First Ave, Room 202
Find more information HERE.


National Drug Early Warning System (NDEWS) Webinar
Opioid Commission: A Summary and Lessons Learned
Wednesday, January 10, 2:00-3:00pm
Bertha K. Madras, PhD - Harvard Medical School
Find more information and register for the event HERE.


Improving Implementation of Seek, Test, Treat & Retain Strategies among People Who Inject Drugs in Low to Middle Income Countries (R01 - Clinical Trial Required)
This FOA supports developing and testing implementation approaches that scale-up evidence based interventions in low to middle income countries among PWID where they form an important component of the national HIV epidemic, including countries where PWID are a relatively emergent population for HIV cases.

Identification of Biomarkers of HIV-1 Pathogenesis and Substance Abuse Comorbidity (R01 - Clinical Trial Not Allowed)
The goal of this Funding Opportunity Announcement [FOA] is to support research that will define and validate a set(s) of molecular biomarkers and/or bio-signatures indicating the degree of loss of functional reserve, or of resilience of the host defense mechanisms, at different phases of HIV-1 pathogenesis in individuals with substance use disorders (SUDs).

Diagnosis, Initiation of Treatment, and Retention of African Americans and Hispanics/Latinos along the HIV Care Continuum
PCORI will be funding studies comparing the clinical effectiveness of interventions of different models of early detection, identification, treatment, and retention to improve patient-centered outcomes for African Americans and Hispanics/Latinos individuals living with HIV. A town hall, to provide an overview of PCORI and the information applicants may need to submit, will be held on 02/01/2018 (register HERE).


Synthetic Psychoactive Drugs and Strategic Approaches to Counteract Their Deleterious Effects (Clinical Trial Optional)

Community Partnerships to Advance Research (CPAR) (Clinical Trial Optional)

Self-Management for Health in Chronic Conditions (Clinical Trial Optional)

Research on Comparative Effectiveness and Implementation of HIV/AIDS and Alcohol Interventions (R01 Clinical Trial Optional)

International Research Scientist Development Award (IRSDA) (K01)
(Clinical Trial Required)
(Clinical Trial Not Allowed)


Concheiro M, Blandino V, Wetzel J, Kim J, & Haxhi P (2017) Oral fluid vs. urine analysis to monitor synthetic cannabinoids and classic drugs recent exposure. Current Pharmaceutical Biotechnology, doi: 10.2174/1389201018666171122113934. Find the abstract on the publisher's website HERE.

Cordova D, Heinze J, Hsieh HF, Mistry R, Salas-Wright CP, Cook SH, & Zimmerman MA (2017) Are trajectories of psychosocial risk in adolescence linked to HIV vulnerability in emerging and young adulthood? an eighteen-year longitudinal study. AIDS, doi: 10.1097/QAD.0000000000001717. Find the abstract on the publisher's website HERE.

Goedel WC, Schneider JA, Hambrick HR, Kreski NT, Morganstein JG, Park SH, Mgbako O, & Duncan DT (2017) Are anal sex roles associated with preferences for pre-exposure prophylaxis administration modalities among men who have sex with men? Archives of Sexual Behavior, doi: 10.1007/s10508-017-1083-5. Find the abstract on the publisher's website HERE.

Goldsamt LA, Clatts MC, Giang LM, Le BQ, Colby DJ, & Yu G (2017) HIV and other STIs in male sex workers: findings from a sexual health promotion intervention in Vietnam. International Journal of STD & AIDS, doi: 10.1177/0956462417740291. Find the abstract on the publisher's website HERE.

Han BH & Moore AA (2018) Prevention and screening of unhealthy substance use by older adults. Clinics in Geriatric Medicine, 34, 117-129. Find the abstract on the publisher's website HERE.

Sherman SE, Krebs P, York LS, Cummins SE, Kuschner W, Guvenc-Tuncturk S, & Zhu SH (2018) Telephone care co-ordination for tobacco cessation: randomised trials testing proactive versus reactive models. Tobacco Control, 27, 78-82. Find the abstract on the publisher's website HERE.


American Society of Addiction Medicine Annual Conference
April 12-15 - San Diego, CA
Second-round call for poster abstracts open through January 26

The College on Problems of Drug Dependence (CPDD) Annual Meeting
June 9-14 - San Diego, CA
NIDA Director's Travel Awards available, submit by Jan 12
CPDD International Committee Travel Awards available, submit by Jan 12

NIH Institute on Randomized Clinical Trials
July 8-19 - Warrenton, VA
Applications are being accepted through February 23

International AIDS Conference
July 23-27 - Amsterdam, Netherlands
Abstracts are being accepted through February 5
Deadline for submitting abstracts through the Abstract Mentor Programme is January 15


The Department of Social and Behavioral Sciences at the Harvard TH Chan School of Public Health is seeking candidates for a tenure track position as Assistant/Associate Professor. The focus is on Population Health & Health Equity. Find more information HERE.

The L’Oréal USA For Women in Science Fellowship Program
This program awards five women postdoctoral scientists annually with grants of $60,000 each for their contributions in Science, Technology, Engineering and Math (STEM) fields and commitment to serving as role models for younger generations. Applicants must be involved in the life, physical/material sciences, engineering, technology, computer science, and/or mathematics fields. Additional eligible areas of study include: immunology, all areas of chemistry, earth science and medical research. Psychology, science education and social science are not eligible for this Fellowship.’oréal-usa-for-women-in-science-program